Retour
41
46
15
29
42
28
Fourchette du Jour
32,18 €
36,10 €
Fourchette 52 Semaines
19,90 €
36,14 €
Volume
100
Moyenne 50J / 200J
35,21 €
/
32,30 €
Clôture Précédente
32,18 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (631 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 5,4 | 0,2 |
| P/B | 1,0 | 3,0 |
| ROE % | 20,2 | 3,6 |
| Net Margin % | 19,0 | 3,8 |
| Rev Growth 5Y % | 12,6 | 10,0 |
| D/E | 0,1 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
0,00 €
0,00 € – 0,00 €
|
10,40B | 0 |
| FY2029 |
9,86 €
9,77 € – 9,95 €
|
9,96B | 1 |
| FY2028 |
8,00 €
7,92 € – 8,07 €
|
8,96B | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-19 | 1,30 € | 0,19 € | -85,5% |
| 2025-11-12 | 0,16 € | 0,22 € | +40,2% |
| 2025-08-21 | 0,20 € | 0,19 € | -7,6% |
| 2025-05-06 | 0,20 € | 0,24 € | +20,4% |
| 2025-02-19 | 0,14 € | 0,11 € | -22,0% |
| 2024-11-14 | 0,12 € | 1,00 € | +744,6% |
| 2024-08-23 | 0,09 € | 0,13 € | +44,4% |
| 2024-05-02 | 1,00 € | 1,10 € | +10,0% |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Mar 17, 2026 | Mar 19, 2026 | 0,25 € | 0,77% |
| Mar 16, 2017 | Mar 20, 2017 | 100,00 € | 3,65% |
| Mar 11, 2016 | — | 100,00 € | 3,71% |
| Mar 13, 2015 | — | 100,00 € | 4,42% |
| Mar 13, 2014 | — | 100,00 € | 3,91% |
| Mar 13, 2013 | — | 100,00 € | 7,46% |
| Mar 28, 2012 | — | 100,00 € | 6,63% |
| Apr 04, 2011 | — | 100,00 € | 8,45% |
| Mar 29, 2010 | — | 100,00 € | 6,25% |
Points Clés
Revenue grew 12,61% annually over 5 years — strong growth
Earnings grew 46,54% over the past year
ROE of 20,24% indicates high profitability
Net margin of 18,96% shows strong profitability
Debt/Equity of 0,07 — conservative balance sheet
Generating 1,54B in free cash flow
Croissance
Revenue Growth (5Y)
12,61%
Revenue (1Y)13,74%
Earnings (1Y)46,54%
FCF Growth (3Y)131,05%
Qualité
Return on Equity
20,24%
ROIC18,17%
Net Margin18,96%
Op. Margin26,35%
Sécurité
Debt / Equity
0,07
Current Ratio3,38
Interest Coverage72,30
Valorisation
P/E Ratio
5,42
Forward P/E5,19
P/B Ratio1,01
EV/EBITDA3,41
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 13,74% | Revenue Growth (3Y) | 14,26% |
| Earnings Growth (1Y) | 46,54% | Earnings Growth (3Y) | 56,76% |
| Revenue Growth (5Y) | 12,61% | Earnings Growth (5Y) | 52,82% |
| Profitability | |||
| Revenue (TTM) | 6,30B | Net Income (TTM) | 1,19B |
| ROE | 20,24% | ROA | 13,05% |
| Gross Margin | 65,87% | Operating Margin | 26,35% |
| Net Margin | 18,96% | Free Cash Flow (TTM) | 1,54B |
| ROIC | 18,17% | FCF Growth (3Y) | 131,05% |
| Safety | |||
| Debt / Equity | 0,07 | Current Ratio | 3,38 |
| Interest Coverage | 72,30 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 5,42 | Forward P/E | 5,19 |
| P/B Ratio | 1,01 | P/S Ratio | 1,03 |
| PEG Ratio | 0,91 | Forward PEG | N/A |
| EV/EBITDA | 3,41 | Fwd EV/EBITDA | 3,80 |
| Forward P/S | 0,91 | Fwd Earnings Yield | 19,27% |
| FCF Yield | 23,74% | ||
| Market Cap | 6,48B | Enterprise Value | 5,66B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 6,30B | 5,54B | 4,82B | 4,51B | 3,92B |
| Net Income | 1,19B | 815,00M | 486,00M | 335,00M | 219,00M |
| EPS (Diluted) | 5,41 | 3,68 | 2,20 | 1,51 | 0,99 |
| Gross Profit | 4,15B | 3,55B | 3,04B | 2,79B | 2,40B |
| Operating Income | 1,66B | 1,09B | 666,00M | 470,00M | 292,00M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 9,15B | 8,25B | 6,73B | 6,31B | 5,83B |
| Total Liabilities | 2,72B | 2,87B | 2,28B | 2,32B | 2,35B |
| Shareholders' Equity | 6,43B | 5,37B | 4,45B | 3,99B | 3,48B |
| Total Debt | 418,00M | 1,19B | 765,00M | 696,00M | 710,00M |
| Cash & Equivalents | 1,24B | 589,00M | 474,00M | 221,00M | 194,00M |
| Current Assets | 4,48B | 3,29B | 2,97B | 2,65B | 2,40B |
| Current Liabilities | 1,33B | 1,95B | 1,31B | 1,40B | 1,39B |
Scores de Stratégies
This stock passed the criteria for 6 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#598 of 1049
Custom
Capital Light Compounder
#83 of 220
#153 of 158
#154 of 203
Custom
Balanced Risk
#102 of 153
Custom
Lower Risk
#131 of 141
Activité Récente
Sorti
Contrarian Investing (David Dreman)
Mar 26, 2026
Entré
Cash Flow Compounder
Mar 24, 2026
Entré
Capital Light Compounder
Mar 24, 2026
Entré
Contrarian Investing (David Dreman)
Mar 24, 2026
Entré
Growth Investing (Philip Fisher)
Mar 24, 2026
Entré
Value Investing (Warren Buffett)
Mar 24, 2026
Entré
Balanced Risk
Mar 24, 2026
Entré
Lower Risk
Mar 24, 2026